4.4 Article

Long-Term Effects of Safinamide on Mood Fluctuations in Parkinson's Disease

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Use of monoamine oxidase inhibitors in chronic neurodegeneration

Peter Riederer et al.

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2017)

Article Neurosciences

Effects of Safinamide on Pain in Fluctuating Parkinson's Disease Patients: A Post-Hoc Analysis

Carlo Cattaneo et al.

JOURNAL OF PARKINSONS DISEASE (2017)

Review Biochemistry & Molecular Biology

Overview of Glutamatergic Dysregulation in Central Pathologies

Tanya Miladinovic et al.

BIOMOLECULES (2015)

Article Clinical Neurology

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

Rupam Borgohain et al.

MOVEMENT DISORDERS (2014)

Review Pharmacology & Pharmacy

Non-dopaminergic Treatments for Motor Control in Parkinson's Disease

Susan H. Fox

DRUGS (2013)

Article Clinical Neurology

Mood disorders in Parkinson's disease

Louis C.S. Tan

PARKINSONISM & RELATED DISORDERS (2011)

Review Psychiatry

Glutamatergic Modulators: The Future of Treating Mood Disorders?

Carlos Zarate et al.

HARVARD REVIEW OF PSYCHIATRY (2010)

Article Clinical Neurology

Safinamide - From molecular targets to a new anti-Parkinson drug

C. Caccia et al.

NEUROLOGY (2006)

Review Clinical Neurology

Non-motor symptoms of Parkinson's disease: diagnosis and management

KR Chaudhuri et al.

LANCET NEUROLOGY (2006)

Review Clinical Neurology

Beyond monoamines: Glutamatergic function in mood disorders

A Kugaya et al.

CNS SPECTRUMS (2005)